Tracking cancer drugs in living cells by thermal profiling of the proteome
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Mapping human drug targets in the cell: To understand both the beneficial and the side effects of a drug, one would need to know its full binding profile to all cellular proteins. Savitski et al. take significant steps toward meeting this daunting challenge. They monitored the unfolding or “melting” of over 7000 human proteins and measured how small-molecule binding changes individual melting profiles. As a proof of principle, over 50 targets were identified for an inhibitor known to bind a broad spectrum of kinases. Two cancer drugs, vemurafib and Alectinib, are known to have a side effect of photosensitivity. The thermal profiling approach identified drug-protein interactions responsible for these side effects. Science , this issue 10.1126/science.1255784
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thermal proteome profiling (TPP, Savitski et al, 2014) is a mass-spectrometry (MS) based functional proteomics method that can identify shifts in protein thermal stability across different conditions (Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“Especially in combination with quantitative changes measured by e.g., phosphoproteomics, TPP can be used to identify functionally relevant alterations and link them to signaling and phenotypic consequences (Savitski et al, 2014; Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“TPP has been used successfully in the past for drug profiling, but it generates complex data that are difficult to interpret and potentially benefit from integration with other data types (Savitski et al, 2014; Perrin et al, 2020; Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“Thermal stabilization (i) is leveraged in thermal proteomics profiling (TPP), an approach that has been employed to, for instance, identify the ferrochelatase FECH as a frequent off-target of kinase inhibitors,224 or to uncover leucine aminopeptidase 3 as an off-target of several HDAC inhibitors.225”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [224]
In the citing paper
“This assay is based on the concept that binding of a compound to a protein can result in thermal stabilization of the protein and-consequently-in a detectable shift of its melting curve.”
From Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer (2021) · cites this paper as Savitski et al., 2014
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eden, E., Navon, R., Steinfeld, I., Lipson, D., & Yakhini, Z. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-48 · Cited by 3,356
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Self-citationDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Bollag, G., Hirth, P., Tsai, J., Zhang, J., Ibrahim, P. N., Cho, H., Spevak, W., Zhang, C., Zhang, Y., Habets, G., et al. (2010) · Nature · doi:10.1038/nature09454 · Cited by 1,831
Mass-spectrometry-based draft of the human proteome
Wilhelm, M., Schlegl, J., Hahne, H., Gholami, A. M., Lieberenz, M., Savitski, M. M., Ziegler, E., Butzmann, L., Gessulat, S., Marx, H., et al. (2014) · Nature · doi:10.1038/nature13319 · Cited by 1,820
Self-citationOverriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
Shah, N. P., Tran, C., Lee, F. Y., Chen, P., Norris, D., & Sawyers, C. L. (2004) · Science · doi:10.1126/science.1099480 · Cited by 1,796
Kulak, N. A., Pichler, G., Paron, I., Nagaraj, N., & Mann, M. (2014) · Nature Methods · doi:10.1038/nmeth.2834 · Cited by 1,719
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1328 · Cited by 1,034
Self-citation
Cited by
Items 401–500 of 1,004
Validating Small Molecule Chemical Probes for Biological Discovery
Vu, V., Szewczyk, M. M., Nie, D. Y., Arrowsmith, C. H., & Baršytė-Lovejoy, D. (2022) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-032620-105344 · Cited by 28
Mass spectrometric exploration of phytohormone profiles and signaling networks
Chen, Y., Wang, Y. N., Liang, X., Zhang, Y., & Fernie, A. R. (2022) · Trends in Plant Science · doi:10.1016/j.tplants.2022.12.006 · Cited by 26
Measurement of drug-target engagement in live cells by two-photon fluorescence anisotropy imaging
Vinegoni, C., Feruglio, P. F., Brand, C., Lee, S., Nibbs, A. E., Stapleton, S., Shah, S., Gryczyński, I., Reiner, T., Mazitschek, R., et al. (2017) · Nature Protocols · doi:10.1038/nprot.2017.043 · Cited by 29
Türkowsky, D., Lohmann, P., Mühlenbrink, M., Schubert, T., Adrian, L., Goris, T., Jehmlich, N., & von Bergen�, M. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.05.018 · Cited by 28
An industry perspective on drug target validation
Jones, L. H. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1182484 · Cited by 26
“directly with its target proteins.[6] Transcriptional and metabolomics changes can also be assessed in the presence of the compound to provide pathway and target information for the”
BackgroundHan, J., Fu, J., Sun, J., Hall, D. R., Yang, D., Blatz, D. J., Houck, K. A., Ng, C. A., Doering, J. A., LaLone, C. A., et al. (2021) · Environmental Science & Technology · doi:10.1021/acs.est.1c00509 · Cited by 27
Chemical proteomics accelerates the target discovery of natural products
He, S., Li, J., Zhou, J.-C., Yang, Z., Liu, X., & Ge, Y. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116609 · Cited by 30
CETSA-based target engagement of taxanes as biomarkers for efficacy and resistance
Langebäck, A., Bacanu, S., Laursen, H., Mout, L., Seki, T., Erkens‐Schulze, S., Ramos, A. D., Berggren, A., Cao, Y., Hartman, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-55526-8 · Cited by 29
Self-citationThe toxic natural product tutin causes epileptic seizures in mice by activating calcineurin
Han, Q., Yang, W., Zang, C., Zhou, L., Zhang, C., Bao, X., Cai, J., Li, F., Shi, Q., Wang, X., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01312-y · Cited by 25
“Hence, TPP as an alternative modification-free strategy, was used to study the target of tutin in primary hippocampal neurons.(29,30) The primary hippocampal neurons were incubated in situ with 5 μM of tutin or PBS for 3 h, and then exposed to differnent temperatures for 3 min.”
MethodFriman, T., Chernobrovkin, A. L., Molina, D. M., & Arnold, L. H. (2020) · SLAS DISCOVERY · doi:10.1177/2472555220973597 · Cited by 25
Self-citationDheeraj, A., Garcia-Marques, F. J., Tailor, D., Bermudez, A., Resendez, A., Pandrala, M., Grau, B. W., Kumar, P., Haley, C. B., Honkala, A. T., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101552 · Cited by 34
Khusainov, I. S., Romanov, N., Goemans, C., Turoňová, B., Zimmerli, C. E., Welsch, S., Langer, J. D., Typas, A., & Beck, M. (2024) · Nature Communications · doi:10.1038/s41467-024-49084-5 · Cited by 26
Labeled and Label-Free Target Identifications of Natural Products
Wang, S., Zhang, Y., Yu, R., Yue, C., Liu, R., Yu, J., Qu, Z., Zhang, W., & Zhuang, C. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01576 · Cited by 27
Cayer, D. M., Nazor, K. L., & Schork, N. J. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw214 · Cited by 29
“thermal shift assay (CETSA) in tandem with quantitative MS (43).”
MethodDetectives and helpers: Natural products as resources for chemical probes and compound libraries
Parthasarathy, A., Mantravadi, P. K., & Kalesh, K. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107688 · Cited by 24
A Comparison of Two Stability Proteomics Methods for Drug Target Identification in OnePot 2D Format
Xu, Y., West, G. M., Abdelmessih, M., Troutman, M. D., & Everley, R. A. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00317 · Cited by 24
Novel approaches to map small molecule–target interactions
Kapoor, S., Waldmann, H., & Ziegler, S. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.05.020 · Cited by 35
Xu, H., Gopalsamy, A., Hett, E. C., Salter, S. C., AULABAUGH, A. E., Kyne, R. E., Pierce, B. S., & Jones, L. H. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob01078d · Cited by 25
Biophysics: for HTS hit validation, chemical lead optimization, and beyond
Genick, C. C., & Wright, S. K. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1349096 · Cited by 24
“profile off target interactions or identify pathways by using quantitative MS [36].”
BackgroundWoodland, B., Farrell, L. A., Brockbals, L., Rezcallah, M. C., Brennan, A., Sunnucks, E. J., Gould, S. T., Stanczak, A. M., O’Rourke, M. B., & Padula, M. P. (2025) · PROTEOMICS · doi:10.1002/pmic.13983 · Cited by 26
“Several denaturant based methods, such as TPP [208] and SPROX [209], require the protein to aggregate and be removed from the solutionasaresultofapplyingadenaturantperturbation.”
Al-Amin, R. A., Gallant, C. J., Muthelo, P. M., & Landegren, U. D. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c02225 · Cited by 23
Taki, A. C., Wang, T., Nguyen, N. N., Ang, C., Leeming, M. G., Nie, S., Byrne, J. J., Young, N. D., Zheng, Y., Ma, G., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1014804 · Cited by 23
“TPP is an advanced, multiplexed mass-spectrometry method that allows the unbiased identification or detection of drug targets (Savitski et al., 2014; Perrin et al., 2020; Mateus et al., 2022); it relies on the thermostability of protein-drug interactions to identify potential target protein(s) through denaturation pro…”
BackgroundGuzmán, U. H., Aksnes, H., Ree, R., Krogh, N., Jakobsson, M. E., Jensen, L. J., Arnesen, T., & Olsen, J. V. (2023) · Nature Communications · doi:10.1038/s41467-023-40224-x · Cited by 29
“Changes in protein associations can therefore be inferred through thermal stability readouts in a large-scale manner by mass spectrometry 68,69 .”
Molecular profiling of sponge deflation reveals an ancient relaxant-inflammatory response
Ruperti, F., Becher, I., Stokkermans, A., Wang, L., Marschlich, N., Potel, C., Maus, E., Stein, F., Drotleff, B., Schippers, K. J., et al. (2024) · Current Biology · doi:10.1016/j.cub.2023.12.021 · Cited by 23
Self-citationStability-based approaches in chemoproteomics
George, A. L., Dueñas, M. E., Marín‐Rubio, J. L., & Trost, M. (2024) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2024.6 · Cited by 26
“Originally, TMT-10plex was recommended to label 10 temperatures for melting curve generation, requiring two batches per biological replicate for both treatment and control conditions (Refs 21, 22).”
BackgroundMethodInfluentialIdentification of protein binding partners of small molecules using label-free methods
Saxena, C. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1227316 · Cited by 24
“Using staurosporine as a test-molecule affinity-based method identified 229 kinases as its putative binding partners [60], whereas TPP, after the set qualification criteria, was able to identify total of only 92 kinases [56].”
BackgroundMethodInfluentialPROMIS: Global Analysis of PROtein‐Metabolite Interactions
Sokołowska, E., Schlossarek, D., Luzarowski, M., & Skirycz, A. (2019) · Current Protocols in Plant Biology · doi:10.1002/cppb.20101 · Cited by 24
OmicScope unravels systems-level insights from quantitative proteomics data
Reis‐de‐Oliveira, G., Carregari, V. C., de Sousa, G. R. D. R., & Martins‐de‐Souza, D. (2024) · Nature Communications · doi:10.1038/s41467-024-50875-z · Cited by 26
Exploring protein conformations with limited proteolysis coupled to mass spectrometry
Leene, C. V., Moortel, L. V., Bosscher, K. D., & Gevaert, K. (2024) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2024.11.005 · Cited by 27
Chemical Proteomics Reveals Human Off‐Targets of Fluoroquinolone Induced Mitochondrial Toxicity
Reinhardt, T., Harraoui, Y. E., Rothemann, R. A., Jauch, A. T., Müller-Deubert, S. M., Köllen, M. F., Risch, T., Jacobs, L. H. C., Müller, R., Traube, F. R., et al. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202421424 · Cited by 32
Chang, R. B., Toyoda, H. C., Hobbs, S. J., Hadary, R., Richmond-Buccola, D., Wein, T., Osterman, I. А., Burger, N., Chouchani, E. T., Sorek, R., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2025.07.016 · Cited by 26
Multiscale modelling of drug mechanism and safety
Zhang, J. D., Sach-Peltason, L., Krämer, C., Wang, K., & Ebeling, M. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.12.009 · Cited by 22
Yang, C., Zhu, S., Chen, Y., Liu, Z., Zhang, W., Zhao, C., Luo, C., & Deng, H. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.09.002 · Cited by 23
Analysis of copper-induced protein precipitation across the E. coli proteome
Robison, A. T. R., Sturrock, G. R., Zaengle-Barone, J. M., Wiebelhaus, N., Dharani, A. M., Williams, I. G., Fitzgerald, M. C., & Franz, K. J. (2022) · Metallomics · doi:10.1093/mtomcs/mfac098 · Cited by 22
Berlin, E., Lizano-Fallas, V., del Amor, A. C., Fresnedo, O., & Cristóbal, S. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c04500 · Cited by 24
Sun, S., Zheng, Z., Wang, J., Li, F., He, A., Lai, K., Zhang, S., Lu, J., Tian, R., & Tan, C. S. H. (2023) · Nature Communications · doi:10.1038/s41467-023-43526-2 · Cited by 21
Lee, Y.-J., Song, H., Yoon, Y. J., Park, S.-J., Kim, S., Han, D. C., & Kwon, B. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113920 · Cited by 26
Stuhldreier, F., Schmitt, L., Lenz, T., Lechtenberg, I., Zimmermann, M., Wollnitzke, P., Schliehe‐Diecks, J., Liu, Y., Jäger, P., Geyh, S., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05356-w · Cited by 22
“By use of mass spectrometry, the thermal profiles of affected proteins can be determined and thus respective drugtargets successfully identified [22, 23].”
BackgroundDietary Omega-3 PUFAs in Metabolic Disease Research: A Decade of Omics-Enabled Insights (2014–2024)
Li, J., Lin, Y.-C.-D., Zuo, H., Huang, H., Zhang, T., Bai, J.-W., & Huang, H. (2025) · Nutrients · doi:10.3390/nu17111836 · Cited by 31
“Recent chemoproteomic technologies offer powerful tools for target identification, including Thermal Proteome Profiling (TPP) [132], Limited Proteolysis-Mass Spectrometry (LiP-MS) [133], and Activity-Based Protein Profiling (ABPP) [134,135].”
A Simplified Thermal Proteome Profiling Approach to Screen Protein Targets of a Ligand
Zhang, X., Ruan, C., Zhu, H., Li, K., Zhang, W., Wang, K., Hu, L., & Ye, M. (2020) · PROTEOMICS · doi:10.1002/pmic.201900372 · Cited by 25
Pasquer, Q. T. L., Tsakoumagkos, I. A., & Hoogendoorn, S. (2020) · Molecules · doi:10.3390/molecules25235702 · Cited by 23
“Interestingly, TPP not only sheds light on direct targets but also gives information on downstream effectors, making it useful for MOA studies as well as target deconvolution [87,88].”
BackgroundIntegrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer
Lv, S., Wu, Z., Luo, M., Zhang, Y., Zhang, J., Pascal, L. E., Wang, Z., & Wei, Q. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05182-0 · Cited by 24
“TPP is a highthroughput method for accessing ligand binding in living cells based on the thermal stability of proteins [33, 52].”
MethodMass Spectrometry-Based Chemical Proteomics for Drug Target Discoveries
Fedorov, I. I., Lineva, V. I., Tarasova, I. A., & Gorshkov, M. V. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922090103 · Cited by 23
Liu, K., Chen, X., Ren, Y., Liu, C., Lv, T., Liu, Y., & Zhang, Y. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110239 · Cited by 27
Ji, H., Lu, X. M., Zhao, S., Wang, Q., Liao, B. Y., Bauer, L. G., Huber, K., Luo, R., Tian, R., & Tan, C. S. H. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2023.08.002 · Cited by 22
Binding Mechanism of the N-Terminal SH3 Domain of CrkII and Proline-Rich Motifs in cAbl
Bhatt, V. S., Zeng, D., Krieger, I. V., Sacchettini, J. C., & Cho, J. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.05.008 · Cited by 22
Time, space, and disorder in the expanding proteome universe
Minde, D., Dunker, A. K., & Lilley, K. S. (2017) · PROTEOMICS · doi:10.1002/pmic.201600399 · Cited by 22
“A small number of TPP runs in human cells and cell lysates enabled quantitatively tracing drug interactions with nearly 7000 human proteins and revealed off-target interactions of a drug [75].”
BackgroundMcClure, R. A., & Williams, J. D. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00181 · Cited by 22
A one-pot analysis approach to simplify measurements of protein stability and folding kinetics
Liu, Y., Chen, H.-Y., Chueh, P. J., & Liu, P.-F. (2018) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2018.12.006 · Cited by 22
Weigt, D., Parrish, C. A., Krueger, J. A., Oleykowski, C. A., Rendina, A. R., & Hopf, C. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.06.004 · Cited by 21
Kaur, U., Johnson, D. T., & Jones, L. M. (2020) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.0c00014 · Cited by 20
Large-scale characterization of drug mechanism of action using proteome-wide thermal shift assaysPreprint
Vranken, J. G. V., Li, J., Mintseris, J., Wei, T.-Y., Sniezek, C. M., Gadzuk-Shea, M. M., Gygi, S. P., & Schweppe, D. K. (2024) · eLife · doi:10.7554/elife.95595 · Cited by 32
Liu, Y., Guo, C.-W., Luo, Q.-M., Guo, Z., Chen, L., Ishihama, Y., Li, P., Yang, H., & Gao, W. Y. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2024.342755 · Cited by 20
Microparticle-Assisted Precipitation Screening Method for Robust Drug Target Identification
Lyu, J., Ruan, C., Zhang, X., Wang, Y., Li, K., & Ye, M. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c02756 · Cited by 20
Chemoproteomics for Plasmodium Parasite Drug Target Discovery
Lu, K., Mansfield, C. R., Fitzgerald, M. C., & Derbyshire, E. R. (2021) · ChemBioChem · doi:10.1002/cbic.202100155 · Cited by 21
High-Throughput Cellular Thermal Shift Assay Using Acoustic Transfer of Protein Lysates
Owens, A. E., Iannotti, M. J., Sanchez, T. W., Voss, T. C., Kapoor, A., Hall, M. D., Marugán, J., Michael, S., Southall, N. T., & Henderson, M. J. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.1c00760 · Cited by 21
Secretomics—A Key to a Comprehensive Picture of Unconventional Protein Secretion
Poschmann, G., Bahr, J., Schrader, J., Stejerean‐Todoran, I., Bogeski, I., & Stühler, K. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.878027 · Cited by 20
“…approach to identify and quantify all proteins secreted by a cell - is inherently unbiased towards a specific secretion pathway and has been successfully applied in several research areas (for a detailed review, see (Mukherjee and Mani, 2013; Schaaij-Visser et al., 2013; Wei et al., 2021).”
BackgroundNakane, K., Nagasawa, H., Fujimura, C., Koyanagi, E., Tomoshige, S., Ishikawa, M., & Sato, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911622 · Cited by 25
“Methods for comprehensively identifying ligand-binding proteins independent of affinity strength include protein crosslinking [4], thermal profiling [5], and irreversible covalent labeling of ligand-binding proteins in a proximity-dependent manner.”
BackgroundSabatier, P., Beusch, C. M., Meng, Z., & Zubarev, R. A. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c03506 · Cited by 23
Global profiling of AMG510 modified proteins identified tumor suppressor KEAP1 as an off-target
Wang, Y., Zhong, B., Xu, C., Zhan, D., Zhao, S., Wu, H., Liu, M., Lan, X., Cai, D., Ding, Q., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106080 · Cited by 20
“, thermal proteome profiling (TPP)(28,29) and solvent-induced protein precipitation (SIP),(30) which can avoid such complications, have been used for both covalent and noncovalent inhibitors such as TNP-470, staurosporine, ouabain, and dasatinib.(31,32) However, these indirect characterization methods are often cumber…”
BackgroundMcCracken, N. A., Liu, H., Runnebohm, A. M., Wijeratne, H. R. S., Wijeratne, A. B., Staschke, K. A., & Mosley, A. L. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100630 · Cited by 20
“The biophysical based cellular thermal shift assay and thermal proteome profiling (TPP) have been used for nearly a decade to study biochemical phenomena in the cellular context (1, 2).”
BackgroundEvolution of Slow-Binding Inhibitors Targeting Histone Deacetylase Isoforms
Mukherjee, A., Zamani, F., & Suzuki, T. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01160 · Cited by 23
Ye, S., Ma, L., Zhang, R., Liu, F., Jiang, P., Xu, J., Cao, H., Du, X., Lin, F., Cheng, L. Y., et al. (2019) · Clinical Proteomics · doi:10.1186/s12014-019-9242-4 · Cited by 20
del Amor, A. C., Freitas, S., Urbatzka, R., Fresnedo, O., & Cristóbal, S. (2019) · Marine Drugs · doi:10.3390/md17060371 · Cited by 23
“We attempted to apply the TPP method as described for drug discovery [8].”
BackgroundMethodInfluentialChd8 regulates X chromosome inactivation in mouse through fine-tuning control of Xist expression
Cerase, A., Young, A. N., Ruiz, N. B., Buneß, A., Sant, G. M., Arnold, M., Giacomo, M. D., Ascolani, M., Kumar, M., Hierholzer, A., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01945-1 · Cited by 21
Hatstat, A. K., Quan, B., Bailey, M. A., Fitzgerald, M. C., Reinhart, M. C., & McCafferty, D. G. (2021) · RSC Chemical Biology · doi:10.1039/d1cb00103e · Cited by 19
Fang, H., Li, P., Shen, C., Tang, F., Ding, A., Bai, H., Peng, B., Yang, X., Li, Z., Huang, K., et al. (2023) · Science China Chemistry · doi:10.1007/s11426-023-1602-7 · Cited by 20
Zhang, Y., Cao, Y., Wu, X., Chen, Z., Chen, B., Wang, A., Guo, Y., Chen, W., Xue, R., Liu, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53238-w · Cited by 24
Studying epigenetic complexes and their inhibitors with the proteomics toolbox
Weigt, D., Hopf, C., & Médard, G. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0244-z · Cited by 19
“Another expansion of the toolbox is an approach based on the successful combination of cellular thermal shift assays (CETSA) and bottom-up proteomics [122, 123].”
MethodAdvanced proteomics approaches to unravel protein homeostasis
Grandi, P., & Bantscheff, M. (2019) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2019.02.001 · Cited by 20
Self-citationRay, S., Lach, R., Heesom, K. J., Valekunja, U. K., Encheva, V., Snijders, A. P., & Reddy, A. B. (2019) · Life Science Alliance · doi:10.26508/lsa.201900603 · Cited by 18
“…defines additional cellular targets for circadian modulators Recent studies have demonstrated that changes in the thermal stability of proteins upon ligand binding can be used to identify targets of small molecules or drugs (Martinez Molina et al, 2013; Savitski et al, 2014; Miettinen et al, 2018).”
BackgroundMethodJacobs-Cachá, C., Puig-Gay, N., Helm, D., Rettel, M., Sellarès, J., Meseguer, A., Savitski, M. M., Moreso, F., Soler, M. J., Serón, D., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-58197-y · Cited by 22
Self-citationLoss of N-Glycanase 1 Alters Transcriptional and Translational Regulation in K562 Cell Lines
Mueller, W. F., Jakob, P., Sun, H., Clauder‐Münster, S., Ghidelli, S., Ordoñez‐Rueda, D., Böesche, M., Bantscheff, M., Collier, P. G., Haase, B., et al. (2020) · G3 Genes Genomes Genetics · doi:10.1534/g3.119.401031 · Cited by 21
Self-citationEmerging Methods in Chemoproteomics with Relevance to Drug Discovery
Nguyen, C., West, G. M., & Geoghegan, K. F. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6539-7_2 · Cited by 22
“3), but follows the partial digestion step with an additional alternative proteolytic digestion step to increase the number of peptides amenable to bottom up LC-MS and takes advantage of SRM for improved quantitative accuracy.”
InfluentialCETSA-MS-based target profiling of anti-aging natural compound quercetin
Bai, L., Deng, Z., Xu, M., Zhang, Z., Guo, G., Xue, X., Wang, S., Yang, J.-H., & Xia, Z. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116203 · Cited by 18
Cellular thermal shift assay: an approach to identify and assess protein target engagement
Zhang, L., Wang, Y., Chang, Z., Zhou, Z., & Chen, Z. (2024) · Expert Review of Proteomics · doi:10.1080/14789450.2024.2406785 · Cited by 21
“Up to now, the past ten years have witnessed different variants of CETSA, which are respectively termed as thermal proteome profiling (TPP) [24], proteome integral solubility alteration (PISA) [34], image-based in situ CETSA [35] and AlphaScreen-CETSA [36].”
InfluentialChemical proteomics for a comprehensive understanding of functional activity and the interactome
Kozoriz, K., & Lee, J. (2025) · Chemical Society Reviews · doi:10.1039/d5cs00381d · Cited by 21
Über bisherige Denkweisen hinaus – neue Wirkstoffe zur Überwindung der Antibiotika‐Krise
Lakemeyer, M., Zhao, W., Mandl, F. A. M., Hammann, P., & Sieber, S. A. (2018) · Angewandte Chemie · doi:10.1002/ange.201804971 · Cited by 19
Hall, D. R., & Peng, H. (2020) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2020.100655 · Cited by 20
Thermal Proteome Profiling in Zebrafish Reveals Effects of Napabucasin on Retinoic Acid Metabolism
Leijten, N. M., Bakker, P. A., Spaink, H. P., den Hertog, J., & Lemeer, S. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra120.002273 · Cited by 20
“Accordingly, the original TPP protocol (2, 3) was adjusted to make it amenable to zebrafish.”
BackgroundMethodInfluentialProSAP: a GUI software tool for statistical analysis and assessment of thermal stability data
Ji, H., Lu, X. M., Zheng, Z., Sun, S., & Tan, C. S. H. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac057 · Cited by 16
Kalakoti, Y., Yadav, S., & Sundar, D. (2022) · ACS Omega · doi:10.1021/acsomega.2c00424 · Cited by 21
Activity-based annotation: the emergence of systems biochemistry
Rhee, K. Y., Jansen, R. S., & Grundner, C. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.03.017 · Cited by 16
Rewiring of the protein–protein–metabolite interactome during the diauxic shift in yeast
Schlossarek, D., Luzarowski, M., Sokołowska, E., Thirumalaikumar, V. P., Dengler, L., Willmitzer, L., Ewald, J. C., & Skirycz, A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04569-8 · Cited by 25
“In contrast, because TPP/iTSA gives average stability of all the oligomeric states by default, it will mainly reflect the stability of a dominant oligomeric state and hence may miss interactions.”
BackgroundMethodInfluentialMitochondrial dysfunction rapidly modulates the abundance and thermal stability of cellular proteins
Groh, C., Haberkant, P., Stein, F., Filbeck, S., Pfeffer, S., Savitski, M. M., Boos, F., & Herrmann, J. M. (2023) · Life Science Alliance · doi:10.26508/lsa.202201805 · Cited by 21
“Thermal proteome pro fi ling (TPP) makes use of the cellular thermal shift assay (Martinez Molina et al, 2013) and represents the multiplexed quanti fi cation of non-denatured protein fractions as function of temperature (Savitski et al, 2014; Franken et al, 2015; Mateus et al, 2020).”
Self-citationLu, X. M., Liao, B. Y., Sun, S., Mao, Y., Wu, Q. D., Tian, R., & Tan, C. S. H. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c01941 · Cited by 19
Saei, A. A., Lundin, A., Lyu, H., Gharibi, H., Luo, H., Teppo, J., Zhang, X., Gaetani, M., Végvári, Á., Holmdahl, R., et al. (2024) · Advanced Science · doi:10.1002/advs.202401502 · Cited by 18
Chowdhury, T., Cupp‐Sutton, K. A., Guo, Y., Gao, K., Zhao, Z., Burgett, A. W. G., & Wu, S. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00778 · Cited by 19
Inhibitors of Protein Methyltransferases as Chemical Tools
Luo, M. (2015) · Epigenomics · doi:10.2217/epi.15.87 · Cited by 18
Drake, W. R., Hou, C., Zachara, N. E., & Grimes, C. L. (2018) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-018-9754-z · Cited by 22
“CETSA has been coupled with quantitative mass spectrometry to study the effects of a complete cellular proteome when treated with a drug, demonstrating this assay’s high-throughput potential (Savitski et al. 2014).”
Peuget, S., Zhu, J., Sanz, G., Singh, M., Gaetani, M., Chen, X., Shi, Y., Saei, A. A., Visnes, T., Lindström, M. S., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2069 · Cited by 18
“Using quantitative mass spectrometry–based proteomics, TPP measures ligand-induced thermal stabilization or destabilization of proteins (2).”
MethodMultiparametric Assays for Accelerating Early Drug Discovery
Herholt, A., Galinski, S., Geyer, P. E., Rossner, M. J., & Wehr, M. C. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.02.005 · Cited by 21
Intracellular Protein–Drug Interactions Probed by Direct Mass Spectrometry of Cell Lysates
Rogawski, R., Rogel, A., Bloch, I., Gal, M., Horovitz, A., London, N., & Sharon, M. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202104947 · Cited by 20
A Bayesian semi-parametric model for thermal proteome profiling
Fang, S., Kirk, P., Bantscheff, M., Lilley, K. S., & Crook, O. M. (2021) · Communications Biology · doi:10.1038/s42003-021-02306-8 · Cited by 18
Self-citationNon-kinase off-target inhibitory activities of clinically-relevant kinase inhibitors
Brauer, N. R., Kempen, A. L., Hernandez, D. E., & Sintim, H. O. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116540 · Cited by 20
Discovery of a small molecule ligand of FRS2 that inhibits invasion and tumor growth
Kumar, K. S., Brunner, C., Schuster, M., Kopp, L. L., Gries, A., Shen, Y., Jurt, S., Moehle, K., Bruns, D., Grotzer, M. A., et al. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00753-x · Cited by 26
“7e), which is consistent with previous reports [38, 39].”
BackgroundResultThermal unfolding methods in drug discovery
Llowarch, P., Usselmann, L. E. J., Ivanov, D. P., & Holdgate, G. A. (2023) · Biophysics Reviews · doi:10.1063/5.0144141 · Cited by 25
Davies, H., Belda, H., Broncel, M., Dalimot, J., & Treeck, M. (2023) · eLife · doi:10.7554/elife.86367 · Cited by 17
“The supernatant containing eluted peptides was further digested with 100 ng trypsin at 37 °C for 6 h. Samples were acidified with trifluoroacetic acid (TFA) to a final concentration of 0.5% v/v to terminate digestion, and frozen at -80 °C.”
MethodInfluentialGraham, K., Lienau, P., Bader, B., Prechtl, S., Naujoks, J., Lesche, R., Weiske, J., Kuehnlenz, J., Brzezinka, K., Potze, L., et al. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.02.013 · Cited by 18
Lum, K. K., Reed, T. J., Yang, J., & Cristea, I. M. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00826 · Cited by 18
Metadata
- Authors
- Savitski, M. M., Reinhard, F. B. M., Franken, H., Werner, T., Savitski, M. F., Eberhard, D., Molina, D. M., Jafari, R., Dovega, R. B., Klaeger, S., Kuster, B., Nordlund, P., Bantscheff, M., & Drewes, G.
- Affiliations
- GlaxoSmithKline (Germany) (DE)
- Karolinska Institutet (SE)
- German Cancer Research Center (DE)
- Department of Proteomics and Bioanalytics, Technische Universität München, Emil Erlenmeyer Forum 5, Freising, Germany.
- Division of Biophysics, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
- Corresponding author
- Savitski, Mikhail M.
- Reinhard, Friedrich B. M.
- Bantscheff, Marcus
- Drewes, Gerard
- ORCID
- Venue
- Science
- Published
- 2014-10-03
- Volume
- 346
- Issue
- 6205
- Pages
- 1255784-1255784
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2131321938
- Cited by
- 1,187
- References
- 41
- Citations by year
- 2026: 119 · 2025: 138 · 2024: 148 · 2023: 130 · 2022: 116 · 2021: 132 · 2020: 95 · 2019: 85 · 2018: 67 · 2017: 56 · 2016: 54 · 2015: 39 · 2014: 5
- FWCI
- 22.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Physical Sciences › Chemistry › Physical and Theoretical Chemistry › thermodynamics and calorimetric analyses
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Keywords
- thermal proteome profiling, drug-target engagement, protein thermal stability, kinase inhibitors, staurosporine, ferrochelatase, vemurafenib, alectinib, phototoxicity, dasatinib, BCR-ABL, cancer drug targets
- MeSH terms
- Adenosine Triphosphatases, Antineoplastic Agents, Hot Temperature, Humans, Ligands, Protein Binding, Protein Denaturation, K562 Cells, Proteome, Proteomics, Protein Stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.